During an acute STEMI event, seconds count. The earlier you can identify the onset of STEMI, the sooner you can make informed clinical decisions and deliver treatment.

Will it be clot-busting thrombolytics, or PCI in the cath lab? Sending a 12-lead ECG transmission from the field to multiple locations within the hospital can help corroborate an initial diagnosis and alert appropriate personnel.

Our innovative STEMI solutions can help you streamline workflow and enhance patient care.

Unintended gaps in any phase of STEMI care can cost money. The more effectively you manage the STEMI process, the better you can manage your organization’s financial health. Our monitoring and data management solutions provide your physicians with access to patients’ clinical data and medical records throughout your cardiac care system – anytime and anywhere. It’s good for your STEMI patients and your bottom line.

If you want your cardiac care teams to work together, your technology must work together. The 12‐lead ECG generated by the HeartStart MRx monitor/defibrillator can be simultaneously sent to your ED, cardiographs, monitors, and cath lab, where clinicians can view it on Xcelera, Philips’ cardiovascular information system. This impacts workflow and post-procedure care, both in the hospital and the patient’s home.

First responders can deliver critical STEMI patient information to wherever it’s needed. Your pre-hospital EMS team can send patient data wirelessly using WIFI or cellular technology, with just the press of a button. Our flexible IT solutions let you choose the communication method that fits your workflow.

Application Notes

Industry Resource

By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.